Antleron's co-development of medical devices and advanced therapies will service life science customers in a better way.
To enhance ecosystem-based collaborations Antleron will set up a shared ‘personalised manufacturing 4.0’ hub to bring personalised implants and processes to life.
This R&D hub will have an integrated focus on both 3D printed medical devices as well as cell-based advanced therapies.
Antleron's hub will house dedicated 3D printers and bioreactors, while supporting the development of a personalised R&D environment and quality system. In combination with an experienced team, the hub will enhance customer interaction by providing an integrated service that speeds up and de-risks personalised product development.